Inhaled loxapine reduces/avoids physical restraint in psychotic agitation | WCP


  • Conference reports - RSi Communications
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Inhaled loxapine reduces/avoids physical restraint in psychotic agitation. 

Why this matters

  • In 16 of the agitated patients reduction of the psychomotor excitement allowed the clinicians to remove the physical restraint.  

Study design

  • Spanish investigators analyzed the efficacy and safety of loxapine inhalation powder in acutely agitated patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
  • 43 patients were analyzed (male 51%), with an average age of 37.4 y, diagnosed with schizophrenia (9), schizoaffective disorder (5), or bipolar disorder (29).
  • When the patients presented an agitation episode they inhaled loxapine 9.1 mg, using the staccato system.
  • Efficacy was measured as a change from baseline in the Positive and Negative Syndrome Scale-Excited Component (PANSS-EC) and at one h after administration. 

Key results

  • A mean reduction of 8.7 points (from mean PEC score of 21.2 at baseline to 12.5 at one h after administration) was found in PANSS-EC (t test, P<.0001>
  • In 16 of the total agitated patients reduction of psychomotor excitement allowed the clinicians to remove the physical restraint.
  • In 20 patients physical restraint could be avoided during the whole treatment.
  • 6 of the patients experienced clinical improvement of the psychomotor excitement but it was not possible to remove the physical restraint.